Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 69,101 | 70,477 | 67,002 | 68,820 | 65,990 |
| Cost of Goods | 11,979 | 12,207 | 12,055 | 10,816 | 10,781 |
| Gross Profit | 57,122 | 58,270 | 54,947 | 58,004 | 55,209 |
| Operating Expenses | 63,936 | 63,088 | 62,196 | 67,315 | 55,527 |
| Operating Income | -5,835 | -4,611 | -7,194 | -8,495 | 463 |
| Other Income | -298 | 81 | -176 | -751 | 141 |
| Pre-tax Income | -6,133 | -4,530 | -7,370 | -9,246 | 604 |
| Income Tax | 129 | 88 | 75 | 122 | 116 |
| Net Income Continuous | -6,262 | -4,618 | -7,445 | -9,368 | 488 |
| Net Income | $-6,262 | $-4,618 | $-7,445 | $-9,368 | $488 |
| EPS Basic Total Ops | -0.20 | -0.15 | -0.24 | -0.31 | 0.02 |
| EPS Basic Continuous Ops | -0.20 | -0.15 | -0.24 | -0.31 | 0.02 |
| EPS Diluted Total Ops | -0.20 | -0.15 | -0.24 | -0.31 | 0.02 |
| EPS Diluted Continuous Ops | -0.20 | -0.15 | -0.24 | -0.31 | 0.02 |
| EBITDA(a) | $-4,128 | $-2,878 | $-5,437 | $-6,941 | $2,085 |